Network Operations Associate 2 - Network & Server Operations, NOC Analyst
About the job
- A university degree in Computer Science, Engineering, or a related field.
- Two to four years of IT experience in networks, cloud, or voice.
- Cisco CCNA or another advanced Cisco, Juniper, or AWS industry certification in networking, cloud, collaboration, or voice.
- Knowledge of routing and switching protocols including OSPF, BGP, VLAN, and STP.
- Hands-on experience with Cisco and Juniper networking devices and software-defined wide area network solutions.
- Proficiency in troubleshooting network issues.
- Knowledge of voice traffic and CUCM server is an advantage.
- Good communication and documentation skills.
- Willingness to work shifts from 6 AM to 3 PM or 2 PM to 11 PM and provide weekend support when needed.
- Excellent written and verbal English communication skills.
- Experience coordinating with service providers and managing complex infrastructure environments.
- Cross-cultural awareness and a global mindset.
- Act as a primary contact for infrastructure-related services and ensure alignment with internal standards and guidelines.
- Collaborate with various teams to maintain service quality, security, and compliance.
- Participate in service reviews, continual improvement, and change management sessions.
- Monitor, operate, troubleshoot, and maintain data center, LAN, WAN, voice and video, and public cloud infrastructure with a focus on resiliency and security.
- Manage NOC infrastructure services to meet agreed service levels.
- Configure and troubleshoot SD-WAN, wireless LAN controllers, Juniper Mist, Identity Services Engine, and firewalls.
- Configure, manage, and troubleshoot enterprise routing and switching technologies on Cisco and Juniper platforms.
- Perform network performance monitoring, optimization, and fault resolution.
- Manage IP addressing, subnetting, and network segmentation in BlueCat.
- Deploy, configure, and support SD-WAN solutions such as Cisco Viptela and Meraki or equivalent technologies.
- Participate in project and service reviews, ensuring adherence to budget, quality, process, compliance, and security standards.
- Support incident and major incident management and ensure accurate service documentation.
- Monitor infrastructure service availability, capacity, and performance, and propose improvements where necessary.
- Independently drive system upgrades, patches, and migrations to enhance infrastructure capabilities.
- Document network configurations, changes, and troubleshooting steps.
- Collaborate with systems, storage, and applications teams on integrated solutions.
- Recommend improvements in network design, performance, and automation.
- Stay current with emerging networking technologies and industry trends.
- Experience troubleshooting and resolving incidents.
- Experience implementing changes and fulfilling IT infrastructure requests.
- Experience working on technical issues.
- Ability to communicate and collaborate with end users and service providers.
- Ability to solve problems in a structured and methodical way.
- Proficiency with ServiceNow, ITIL, Cisco, Juniper, AWS, and Azure platforms.
About the company
Alcon provides eye care products and vision solutions to improve how people see. It develops and manufactures devices and consumables for eye health, including cataract surgery equipment and intraocular lenses, retinal health therapies, and contact lenses, distributed through eye care professionals, hospitals, and consumers. The products work by supporting eye surgery, protecting and restoring vision, or correcting vision with lens-based options, backed by research and development and a global distribution network. Alcon differentiates itself with a broad, end-to-end portfolio across the eye care continuum, a strong emphasis on research and development, strategic partnerships with healthcare providers, and a commitment to diversity and inclusion. Its goal is to enhance vision and quality of life by delivering reliable, high-quality eye care solutions and advancing the science of eye health.
Company Size
10,001+
Company Stage
IPO
Headquarters
Geneva, Switzerland
Founded
1945
Get referred to Alcon
See people who can refer or advise you
Simplify's Take
What believers are saying
- Systane PRO PF launched in Canada on September 28, 2026, extending premium dry-eye pricing.
- UNITY CS and UNITY M shipped in September 2026, expanding Alcon's installed base.
- Q2 2026 sales rose 8%, while core EPS grew 11% and cash generation stayed strong.
What critics are saying
- Alcon discontinued PowerVision IOLs in August 2026 after unpredictable postoperative vision outcomes.
- Implantables grew only 1% constant currency in Q2 2026, signaling cataract competition.
- If UNITY adoption slows, Alcon depends on mature cataract tools and Systane cash flow.
What makes Alcon unique
- Alcon's UNITY surgical platform integrates cataract, vitreoretinal, and microscope workflows across 2026 launches.
- Systane's preservative-free dry-eye franchise leads global artificial tears and deepens consumer reach.
- Alcon sells across 140 countries, balancing surgical devices with recurring vision-care consumables.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Medical, dental, & vision coverage
HSA Medical Plan
PTO
Paid Parental leave
401k
Retirement Plan Company Contribution
Low payroll deductions
Tuition Reimbursement Program
Annual Bonus
Free Family Contact Lens Program
12 Company Paid Holidays
Growth & Insights and Company News
6 month growth
↑ 11%1 year growth
↑ 11%2 year growth
↑ 12%Alcon has launched Systane PRO Preservative-Free in Canada, its longest-lasting dry eye relief formula. The triple-action eye drops provide up to 12 hours of symptom relief for all types of dry eyes. The formula contains hyaluronic acid, HP-guar, nano-sized lipids, and propylene glycol to hydrate, restore, and protect dry eyes. It works by covering the eye surface for instant hydration, providing long-lasting lubrication, and stabilising the tear film to prevent evaporation. Dry eye disease affects an estimated 6 million Canadians and 1.6 billion people globally. Systane is the number one global brand of artificial tears. The new preservative-free formulation addresses symptoms caused by ageing, environmental factors, and digital device use.
Introducing Systane(R) PRO PRESERVATIVE-FREE: Alcon's longest lasting, triple-action formula for up to 12 hours of Dry Eye symptom relief. Business Wire Published Sep 28, 2026 * Formulated with hyaluronic acid, Systane(R) PRO PRESERVATIVE-FREE instantly hydrates dry eyes[1] * Systane(R) PRO PF is a multi-dose preservative-free triple action formula that hydrates, restores and protects all types of dry eyes[2-4] * The latest addition to the #1 global consumer brand of artificial tears[5] is now available in Canada TORONTO - Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of Systane(R) PRO Preservative-Free (PF) in Canada as Systane's most advanced formula. Systane PRO PF is the longest lasting dry eye symptom relief eye drop for all types of dry eye in the Systane portfolio with a unique triple action, preservative-free formula that provides up to 12 hours of dry eye relief.[1*] The product is now available in Canada. Story continues below Dry eye disease (DED) is one of the most common ocular surface disorders, affecting an estimated 6 million people in Canada and 1.6 billion globally.[6] Building on Systane's legacy as the #1 global brand of artificial tears,[5] the new formulation includes HP-guar, hyaluronic acid (HA), nano-sized lipids, and the demulcent propylene glycol to hydrate, restore, and protect dry eyes, providing rapid and continued dry eye symptom relief from the first drop.[2-4, 7-9*] "At Alcon, we are committed to ensuring that dry eye sufferers can get the relief they deserve, which is why we are proud to unveil Systane PRO PF, the longest lasting dry eye symptom relief eye drop in the Systane portfolio," said Vanessa Johari Hansen, Country Franchise Head, Vision Care, Alcon Canada.[2] "Systane PRO's PF formula works to provide sustained hydration, restore tear film stability, and protect against further irritation of dry eyes."[3-4] Patients with dry eyes often experience symptoms when moisture retention and tear stability are impacted by a variety of factors, including aging, environment, and digital device use.[10] Combatting these everyday challenges, this new formula covers the surface of the eye for instant hydration and soothing dry eye relief, protects from and prevents further dryness of the eye with long-lasting lubrication,[**] and stabilizes the tear film to prevent from further evaporation.[2-4^] "I have witnessed firsthand how disruptive, and at times debilitating, dry eye symptoms can be," said Dr. François Piuze, optometrist and co-owner of the Eye Am clinics in Quebec City and Montreal. For Eye Care Professionals, pinpointing long-lasting solutions for patients to address the symptoms of this complex and multifactorial disease is critical. That is why it is so exciting that patients in Canada can now experience up to 12 hours of dry eye symptom relief with Systane PRO PF."[2*] As part of Alcon's ongoing efforts to educate audiences around the effects and treatment of DED, the organization recently partnered with the Tear Film & Ocular Surface Society (TFOS) to develop the DEWS III report, building upon the globally recognized body of work that has helped shape clinical understanding of DED. "The report highlights the multifactorial and symptomatic nature of the disease and the importance of providing personalized treatment strategies," notes Dr. Piuze. "This includes first-line foundational treatment options with ingredients like HP-guar and hyaluronic acid (HA), based on individual patient risk factors and disease subtypes." Story continues below To learn more about Systane PRO PF, please visit https://systane.myalcon.com/en-ca/products/systane-pro-preservative-free/ Important Information for the Systane(R) Family of Products Systane lubricant eye drops have been clinically proven to reduce the symptoms of dry eye, providing fast, long-lasting relief and comfort. Systane is the #1 global consumer brand of artificial tears.[5] Systane(R) COMPLETE provides symptom relief for people who suffer from evaporative dry eye, aqueous tear-deficient dry eye or mixed dry eye. Systane(R) ULTRA is designed for dry eye with aqueous deficient patients. Systane(R) BALANCE lubricant eye drops are designed specifically for patients with evaporative dry eye associated with meibomian gland dysfunction. Systane(R) HYDRATION gives long-lasting relief of dry eye symptoms for moderate or chronic sufferers or patients who are recovering from corneal or other eye surgery. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries and territories each year living with conditions like cataracts, glaucoma, retinal diseases, and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals, and programs that advance access to quality eye care. Learn more at *47% of patients experience meaningful symptom relief at 12 hours, N = 153. **Dose: 4 times a day. ^Improvement in NITBUT demonstrated at Day 30 compared to baseline. Dosed 4 times a day. N =316; (p<0.0001). References * Alcon data on file, 2025. REF-26802. * SYSTANE Hydration (HA/HPG) provided effective hydration and lubrication and demonstrated prolonged retention of effect. (p.1). * Rangarajan R, Ketelson H. Preclinical evaluation of a new hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear formulation in models of corneal epithelium. J Ocul Pharmacol Ther. 2019;35(1):32-37. doi:10.1089/jop.2018.0031. * Craig JP, Muntz A, Wang MTM, Luensmann D, Tan J, Trave Huarte S, Xue AL, Jones L, Willcox MDP, Wolffsohn JS. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial. Ocul Surf. 2021 Apr;20:62-69. doi: 10.1016/j.jtos.2020.12.006. Epub 2021 Jan 2. PMID: 33401019. * Alcon data on file, 2025. REF-26802. * Caffery B, Srinivasan S, Reaume CJ, Fischer A, Cappadocia D, Siffel C, Chan CC. Prevalence of dry eye disease in Ontario, Canada: A population-based survey. Ocul Surf. 2019 Jul;17(3):526-531. doi: 10.1016/j.jtos.2019.02.011. Epub 2019 Feb 27. PMID: 30825521. * Kesavan S, Prud'homme RK. Rheology of guar and (hydroxypropyl) guar crosslinked by borate. Macromolecules. 1992;25(7):2026-2032.doi:10.1021/ma00033a029. * Ubels JL, Clousing DP, Van TA, et al. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropylguar as a gelling agent. Curr Eye Res. 2004;28(6):437-444. doi:10.1080/02713680490503787. * Rangarajan R, Kraybill B, Ogundele A, Ketelson HA. Effects of a hyaluronic acid/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497. doi:10.1089/jop.2014.0164. * Market Scope LLC. 2020 Dry Eye Products Report: A Global Market Analysis for 2019 to 2025. St. Louis, MO. Connect with us on (C) 2026 Alcon Inc. CA-SAF-2600098 View source version on businesswire.com: Media Relations
Alcon launches UNITY M, a premium ophthalmic microscope delivering precise control. Alcon announced the initial commercial launch of UNITY M, an Alcon brand premium surgical microscope that delivers precise control to ophthalmic surgeons, in select markets including the U.S. and Japan followed by Europe.[1,2,4] UNITY M will be featured at the upcoming Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). The microscope is the latest addition to Alcon's UNITY platform, combining advanced optics, novel illumination, improved ergonomics, and intuitive usability in a modular design that enables practice-specific customization and future scalability.[1-3,5-7, ,‡,§] "The idea behind the UNITY platform is to develop clinic-based and operating room equipment solutions with a seamless user experience that improve surgical workflows," said Ian Bell, SVP and Chief Operating Officer of Alcon. "By partnering closely with Eye Care Professionals to understand their most significant unmet needs, we developed UNITY M to provide a flexible, future-ready visualization platform that gives surgeons precise control and personalization in the operating room."
Alcon adds second Global Capability Center in Bangalore. * September 7, 2026 Alcon, one of the world's largest eye-care medical device companies, has expanded its Global Capability Center operations in India with the opening of a second Alcon Global Services facility in Bengaluru. The expansion is notable not simply because Alcon is adding office capacity in India, but because of the range of global activities being performed there. The Bangalore operations support functions including information technology, research and development, quality, customer operations, supply chain analytics, finance and digital transformation. Alcon's decision to establish a second location in the same metropolitan area also illustrates the scale that the city has achieved as a center for multinational healthcare and technology operations. The two Alcon locations are roughly an hour apart by car under typical Bengaluru traffic conditions. In a metropolitan area of Bangalore's size, separate locations can potentially provide access to different pools of employees and make commuting more practical for workers living in different parts of the city. Alcon has not, however, identified that as the reason for selecting the second location. This is my assessment having lived in Bangalore and having traveled to this city many times in recent years Gopal Sharma, who leads Alcon Global Services, described the expansion as an investment in talent and future capabilities rather than simply an addition of office space. The company expects the new facility to increase its ability to recruit skilled professionals and support operations elsewhere in the Alcon organization. The type of work being performed is also significant. Global Capability Centers in India were once associated primarily with lower-cost back-office functions such as transaction processing, finance and IT support. That model has changed substantially. Multinational companies increasingly use their India centers for engineering, product development, data analytics, cybersecurity, artificial intelligence and other activities closely connected to their core businesses. While Alcon is not our client, we firmly believe that medical device companies can benefit greatly from leveraging technical talent in many of India's cities. Alcon's operation reflects that evolution. Research and development, quality, supply chain analytics and digital transformation place at least part of the India organization closer to the company's technology and operational decision-making than a conventional shared-services center would be. For medical device companies, India offers a particularly relevant combination of software, engineering and healthcare talent. Modern medical devices increasingly combine physical products with software, data, digital platforms and connected technologies, making some of the skills available in India's technology centers directly applicable to global medical device development. Bangalore, Hyderabad, Delhi NCR (Noida and Gurgaon) and Pune have become one of the principal beneficiaries of this shift. Established technology industry, large engineering workforce and growing life sciences ecosystem have attracted GCC investments from multinational healthcare, pharmaceutical and medical technology companies. Alcon also views India as an important emerging market for its products, giving the country a dual role within the company: it is both a commercial healthcare market and a location from which employees support Alcon's global organization. Opening a second facility in the same city suggests that Alcon sees sufficient value in the city's talent base to continue concentrating operations there rather than shifting the additional capacity to another Indian city. However other companies have chosen to expand their talent people and gain redundancy against disaster by diversifying across multiple locations in India. There is no single right answer. More broadly, the expansion provides another example of how the role of India within multinational medical device companies is changing. The attraction is no longer limited to lower operating costs. For companies such as Alcon, India is increasingly a source of engineering and specialized talent that can participate in R&D, analytics, digital transformation and other work supporting the global business. About amritt. Who we are. Amritt Inc. is a management advisory service facilitating trade between the world and India. Amritt was founded in 2003 and since then it has provided guidance to western companies in entering new markets, global strategy execution, finding and managing supplier partners, and establishing overseas offices. Our primary focus is in helping American, Canadian and European executives to attain success in India.
Alcon launches Unity M ophthalmic microscope. September 04, 2026 Add topic to email alerts Key takeaways: * The microscope is designed for both anterior and posterior segment surgical procedures. * In addition to visualization features, Unity M allows for modular updates over time. Alcon launched Unity M, a surgical microscope designed to increase surgical precision with advanced visualization features for both anterior and posterior segment surgeons, according to a press release. "Through our collaboration with eye care professionals, we heard a consistent need for greater control and reliable visualization during surgery," Sergio Duplan, senior vice president, president, Americas, at Alcon, told Healio. "That's why we built Unity M specifically for ophthalmology, delivering a stable red reflex, color tunable illumination and optimized depth of field to help surgeons visualize tissue more clearly and operate with confidence." The base model's red reflex zone is designed to help maintain consistent visualization across pupil sizes and microscope positions, the release said, while color tunable illumination technology provides improved contrast and tissue detail. Commercial rollout will begin in the U.S. and Japan this year, followed by additional markets. The device is the third addition to Alcon's Unity platform and is built to integrate seamlessly into Alcon's wider portfolio as well as to allow surgeons to adopt customized, modular updates over time, tailoring the system to their clinical needs. Unity M has received CE mark and regulatory approvals in the U.S., India, Europe, Canada and Japan, according to the release, and will be featured at the European Society of Cataract and Refractive Surgeons meeting this month. Published by: Sources/Disclosures. Disclosures: Duplan reports being senior vice president, president, Americas, at Alcon. Ask a clinical question and tap into Healio AI's knowledge base. * PubMed, enrolling/recruiting trials, guidelines * Clinical Guidance, Healio CME, FDA news * Healio's exclusive daily news coverage of clinical data